ClinicalTrials.Veeva

Menu

Effect of Intravenous Dexmedetomidine Versus Dexamethasone for Management of Repound Pain After Supraclavicular Brachial Plexus Block

A

Assiut University

Status and phase

Not yet enrolling
Phase 1

Conditions

Trauma Injury

Treatments

Drug: Dexmedetomidine injection

Study type

Interventional

Funder types

Other

Identifiers

NCT06304909
2080278

Details and patient eligibility

About

Effect of intravenous dexmedetomidine versus dexamethasone for management of repound pain after supraclavicular brachial plexus block.

Enrollment

111 estimated patients

Sex

All

Ages

20 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients between 20_60 years old

    • Patients with ASA clinical status I/II
    • Patients scheduled for peripheral nerve block for upper extremity surgery

Exclusion criteria

    1. they refused to participate 2) had preexisting neuropathy of the surgical limb 3) hypersensitivity to amide anesthetic 4) significant pulmonary disease 5) coagulopathy 6) sepsis 7) infection at the block site 8) hypersensitivity to dexmedetomidine & dexamethasone

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

111 participants in 3 patient groups

Dexmedetomidine group will receive 0.5 mcg/kg
Experimental group
Treatment:
Drug: Dexmedetomidine injection
Dexamethasone group will receive 8mg/kg
Experimental group
Treatment:
Drug: Dexmedetomidine injection
Control group will receive equivalent volume of saline 0.9%.
Experimental group
Treatment:
Drug: Dexmedetomidine injection

Trial contacts and locations

0

Loading...

Central trial contact

Marwa Sayed Mohamed, physician; Mohamed Mohamed Abdellatif, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems